A review on in-silico analysis of immune cell trafficking and interactions with the tumour microenvironment - Summary - MDSpire

A review on in-silico analysis of immune cell trafficking and interactions with the tumour microenvironment

  • By

  • Kharan P.

  • Amy S. Mathew

  • Payel Ghosh

  • Syama H. P.

  • July 3, 2026

  • 0 min

Share

Objective:

To examine existing in silico tools for evaluating immune cell migration, communication, and function in the tumor microenvironment (TME).

Approach:
  • Review of Computational Models: The review discusses various computational modelling techniques such as agent-based models, differential equation models, and machine learning models that simulate immune dynamics in the TME.
  • Assessment of Bioinformatics Resources: The article evaluates bioinformatics databases like TCGA and TIMER for understanding the immune system composition and immunogenomics of tumors.
  • Analysis of Immune Cell Populations: Specific in silico analyses of immune cell populations, including Tumour-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), are examined to demonstrate predictive capabilities.
Key Findings:
  • Immune cell trafficking in TMEs is crucial for determining tumor destruction or immune evasion.
  • Computational models enhance understanding of immune-tumor interactions and the development of immune escape.
  • Integration of multi-omics and spatial transcriptomic datasets aids in personalized modeling for immunotherapy responses.
Interpretation:

The findings support the increasing relevance of computational science in understanding immune-TME interactions and developing cancer immunotherapies.

Limitations:
  • Data heterogeneity poses challenges for model validation.
  • Bulk transcriptomic methods struggle with accurately resolving rare immune cell subpopulations.
  • Validation of simulated immune interactions remains a significant barrier.
Conclusion:

The review emphasizes the importance of bioinformatics and computational tools in cancer research, particularly in the context of precision immunotherapy.

Original Source(s)

Related Content